Jan 20, 2026 05:52PM
Jan 20, 2026 05:35PM
Dec 23, 2025 06:41AM
Dec 22, 2025 04:04PM
Dec 22, 2025 04:03PM
Dec 3, 2025 06:43AM
Dec 2, 2025 07:30AM enGene selected for FDA manufacturing pilot program
Dec 2, 2025 07:30AM
Nov 12, 2025 07:31AM
Nov 11, 2025 07:30AM
Nov 11, 2025 07:30AM
Nov 4, 2025 01:35PM
Sep 30, 2025 07:30AM
Sep 30, 2025 07:30AM enGene Appoints Hussein Sweiti, M.D., MSc, as Chief Medical Officer
Sep 12, 2025 06:45AM
Sep 11, 2025 04:03PM
Sep 3, 2025 07:30AM
Sep 3, 2025 07:30AM
Jul 8, 2025 08:03AM
Jul 8, 2025 08:00AM
Jun 25, 2025 08:00AM Engene (ENGN): FDA Grants RMAT Designation for Detalimogene, Enabling Potential for Expedited Review in High-Risk, Non-Muscle Invasive Bladder Cancer
Jun 25, 2025 08:00AM
Jun 16, 2025 06:40AM
Jun 12, 2025 08:00AM
May 28, 2025 07:30AM
May 28, 2025 07:30AM
Apr 29, 2025 04:18AM
Mar 10, 2025 04:05PM enGene Reports First Quarter 2025 Financial Results and Provides Business Update
Jan 30, 2025 08:00AM
Jan 6, 2025 02:00PM
Dec 19, 2024 04:05PM
Sep 24, 2024 06:35AM
Jun 14, 2024 07:01AM
Nov 1, 2023 07:30AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All